Screener
Eligibility screening
A Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
11 US sites in CO, CT, FL, NV +2
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.